Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

DJ US Pharmaceuticals Ishares (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 650,308,600
  • Shares Outstanding, K 4,050

Price Performance

See More
Period Period Low Period High Performance
1-Month
147.70 +2.39%
on 11/15/17
159.04 -4.91%
on 10/23/17
-7.45 (-4.69%)
since 10/20/17
3-Month
147.70 +2.39%
on 11/15/17
161.20 -6.18%
on 10/04/17
+1.98 (+1.33%)
since 08/22/17
52-Week
135.09 +11.95%
on 12/08/16
161.20 -6.18%
on 10/04/17
+7.95 (+5.55%)
since 11/22/16

Most Recent Stories

More News
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 42.35 (+0.55%)
JNJ : 137.29 (-0.76%)
MRK : 54.37 (+0.18%)
PJP : 62.65 (+0.59%)
IHE : 151.23 (+0.47%)
LLY : 83.68 (+0.20%)
PPH : 56.56 (+0.52%)
PFE : 35.43 (-0.31%)
BMY : 61.14 (-0.16%)
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 42.35 (+0.55%)
JNJ : 137.29 (-0.76%)
MRK : 54.37 (+0.18%)
PJP : 62.65 (+0.59%)
IHE : 151.23 (+0.47%)
LLY : 83.68 (+0.20%)
PPH : 56.56 (+0.52%)
PFE : 35.43 (-0.31%)
BMY : 61.14 (-0.16%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 42.35 (+0.55%)
PJP : 62.65 (+0.59%)
IHE : 151.23 (+0.47%)
PPH : 56.56 (+0.52%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 42.35 (+0.55%)
PJP : 62.65 (+0.59%)
IHE : 151.23 (+0.47%)
PPH : 56.56 (+0.52%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 42.35 (+0.55%)
JNJ : 137.29 (-0.76%)
MRK : 54.37 (+0.18%)
IHE : 151.23 (+0.47%)
PJP : 62.65 (+0.59%)
LLY : 83.68 (+0.20%)
PFE : 35.43 (-0.31%)
BMY : 61.14 (-0.16%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 42.35 (+0.55%)
JNJ : 137.29 (-0.76%)
MRK : 54.37 (+0.18%)
IHE : 151.23 (+0.47%)
PJP : 62.65 (+0.59%)
LLY : 83.68 (+0.20%)
PFE : 35.43 (-0.31%)
BMY : 61.14 (-0.16%)
J&J Brightens Outlook: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.

XLV : 81.58 (-0.04%)
VHT : 152.14 (+0.01%)
JNJ : 137.29 (-0.76%)
IHE : 151.23 (+0.47%)
IYH : 171.91 (-0.13%)
FHLC : 39.50 (+0.05%)
J&J Brightens Outlook: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.

XLV : 81.58 (-0.04%)
VHT : 152.14 (+0.01%)
JNJ : 137.29 (-0.76%)
IHE : 151.23 (+0.47%)
IYH : 171.91 (-0.13%)
FHLC : 39.50 (+0.05%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 42.35 (+0.55%)
PJP : 62.65 (+0.59%)
IHE : 151.23 (+0.47%)
PPH : 56.56 (+0.52%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 42.35 (+0.55%)
PJP : 62.65 (+0.59%)
IHE : 151.23 (+0.47%)
PPH : 56.56 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Key Turning Points

2nd Resistance Point 152.34
1st Resistance Point 151.78
Last Price 151.23
1st Support Level 150.37
2nd Support Level 149.52

See More

52-Week High 161.20
Fibonacci 61.8% 151.23
Last Price 151.23
Fibonacci 50% 148.14
Fibonacci 38.2% 145.06
52-Week Low 135.09

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart